Update for receipt of copy of order related to scheme of Amalgamation of Dhanuka Laboratories limited and Orchid Pharma limited
Disclosure regarding the order passed by Goods and Service Department.
In continuation to our earlier intimation dated March 18, 2026, with respect to merger petition, we would like to inform that Hon'ble National Company Law Tribunal ("NCLT") on June 05, 2026 i.e. today, has allowed our petition sanctioning the scheme of Amalgamation and Arrangement of Dhanuka Laboratories Limited with Orchid Pharma Limited and their respective Shareholders and Creditors, by virtue of which, the Amalgamating Company would stand transferred to and vested in, or deemed to have been transferred and vested in Amalgamated Company on a going concern basis.
Transcript of Analysts/ Investor Earning Call held on May 26, 2026 for the Quarter and Financial Year ended on March 31, 2026
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2026.
Investor / Analysts call recording for the Quarter- 4 and Financial year ending March 31, 2026.
Investor Presentation for Quarter- IV and Financial year ended on March 31, 2026.
Appointment of Internal Auditor of the Company.
Statement of Deviation or Variation for the Quarter and Financial Year ended on March 31, 2026
Board Meeting Outcome for Outcome of Board Meeting for considering and approving Annual Audited Financial Results for the Quarter and Financial Year ended on March 31, 2026
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 182.92 | 198.76 | 220.59 | 217.10 | 244.41 | 222.70 | 217.34 | 237.48 | 172.93 | 193.52 | 207.27 | 237.61 |
| YOY Revenue Growth % | 39.65% | 20.28% | 38.08% | 3.43% | 33.61% | 12.05% | -1.47% | 9.39% | -29.25% | -13.1% | -4.64% | 0.05% |
| Other Income | 1.89 | 8.18 | 7.44 | 12.88 | 7.77 | 7.96 | 9.94 | 6.26 | 15.93 | 15.43 | 10.59 | 13.30 |
| Total Income | 184.81 | 206.94 | 228.03 | 229.99 | 252.18 | 230.66 | 227.28 | 243.74 | 188.86 | 208.95 | 217.86 | 250.90 |
| Total Expenses + | 174.03 | 186.70 | 197.48 | 200.03 | 223.08 | 205.04 | 203.37 | 215.89 | 170.66 | 206.72 | 216.57 | 220.84 |
| Cost of Materials Consumed | 118.41 | 117.86 | 135.62 | 156.47 | 152.77 | 153.72 | 142.02 | 136.94 | 110.16 | 112.27 | 118.97 | 120.95 |
| Employee Benefit Expense | 16.22 | 17.19 | 18.66 | 17.57 | 21.37 | 20.69 | 22.06 | 22.24 | 21.61 | 24.05 | 22.88 | 19.59 |
| Other Expenses | 32.49 | 35.53 | 44.07 | 42.49 | 39.53 | 41.27 | 44.13 | 42.89 | 38.27 | 37.64 | 38.40 | 37.66 |
| Operating Profit | 8.89 | 12.06 | 23.11 | 17.08 | 21.33 | 17.66 | 13.97 | 21.59 | 2.27 | -13.19 | -9.30 | 16.77 |
| OPM % | 4.9% | 6.1% | 10.5% | 7.9% | 8.7% | 7.9% | 6.4% | 9.1% | 1.3% | -6.8% | -4.5% | 7.1% |
| Profit Before Tax + | 10.78 | 20.24 | 30.55 | 29.96 | 29.10 | 25.63 | 23.91 | 27.85 | 18.20 | 2.23 | -5.82 | 30.60 |
| Tax Expense | 0.00 | 0.00 | 0.00 | -3.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax % | 0% | 0% | 0% | -10.8% | 0% | 0% | 0% | 0% | 0% | 0% | - | 0% |
| Profit After Tax | 10.78 | 20.24 | 30.55 | 33.19 | 29.10 | 25.63 | 23.91 | 27.85 | 18.20 | 2.23 | -5.82 | 30.60 |
| EPS (Basic) | 5.28 | 4.40 | 6.42 | 6.86 | 5.74 | 5.05 | 4.71 | 5.49 | 3.59 | 0.44 | -1.15 | 6.03 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Revenue from Operations | 811.33 | 921.93 | 819.37 | 665.90 | 556.97 | 450.70 |
| YOY Revenue Growth % | -12% | 12.52% | 23.05% | 19.56% | 23.58% | - |
| Other Income | 55.24 | 31.93 | 30.39 | 19.43 | 9.00 | 6.48 |
| Total Income | 866.57 | 953.86 | 849.76 | 685.33 | 565.98 | 457.17 |
| Total Expenses + | 814.79 | 847.37 | 758.23 | 669.29 | 618.75 | 553.04 |
| Cost of Materials Consumed | 462.34 | 585.46 | 528.35 | 406.10 | 336.80 | 244.96 |
| Employee Benefit Expense | 88.14 | 86.36 | 69.64 | 65.35 | 60.21 | 64.40 |
| Other Expenses | 151.98 | 167.81 | 154.59 | 132.31 | 125.44 | 99.14 |
| Operating Profit | -3.46 | 74.55 | 61.13 | -3.39 | -61.77 | -102.35 |
| OPM % | -0.4% | 8.1% | 7.5% | -0.5% | -11.1% | -22.7% |
| Profit Before Exceptional | 51.78 | 106.48 | 91.52 | 16.04 | -52.77 | -95.87 |
| Exceptional Items | -6.57 | 0.00 | 0.00 | 39.21 | 0.00 | 0.00 |
| Profit Before Tax + | 45.21 | 106.48 | 91.52 | 55.25 | -52.77 | -95.87 |
| Tax Expense | 0.00 | 0.00 | -3.23 | 1.06 | -47.96 | 21.28 |
| Tax % | 0% | 0% | -3.5% | 1.9% | - | - |
| Profit After Tax | 45.21 | 106.48 | 94.75 | 54.19 | -4.81 | -117.15 |
| EPS (Basic) | 8.91 | 20.99 | 19.59 | 13.28 | -1.18 | -28.70 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Non-Current Assets + | 1,114.13 | 910.19 | 769.91 | 729.46 | 658.88 | 682.22 |
| Property, Plant & Equipment | 591.69 | 612.12 | 615.12 | 572.67 | 583.32 | 670.02 |
| Capital Work in Progress | 95.00 | 27.69 | 10.18 | 46.09 | 9.78 | 7.43 |
| Non-Current Investments | 73.34 | 69.35 | 69.40 | 50.12 | 49.01 | 0.40 |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Intangible Assets | 0.60 | 1.13 | 0.64 | 0.39 | 0.34 | 0.37 |
| Current Assets + | 635.99 | 786.39 | 782.29 | 493.79 | 422.02 | 421.40 |
| Inventories | 256.41 | 326.37 | 264.23 | 228.74 | 172.66 | 150.57 |
| Trade Receivables | 263.87 | 241.83 | 189.37 | 211.91 | 160.23 | 131.96 |
| Cash and Cash Equivalents | 1.24 | 15.87 | 0.29 | 18.31 | 0.45 | 14.75 |
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.02 |
| LIABILITIES & EQUITY | ||||||
| Total Equity | 1,370.15 | 1,324.05 | 1,218.32 | 731.96 | 677.95 | 681.34 |
| Equity Share Capital | 50.72 | 50.72 | 50.72 | 40.82 | 40.82 | 40.82 |
| Other Equity | 1,319.43 | 1,273.33 | 1,167.60 | 691.15 | 637.14 | 640.52 |
| Non-Current Liabilities | 197.16 | 135.06 | 124.21 | 164.67 | 222.40 | 442.26 |
| Current Liabilities | 182.80 | 237.47 | 209.67 | 326.63 | 193.83 | 100.87 |
| Total Liabilities | 379.96 | 372.53 | 333.89 | 491.30 | 416.24 | 543.13 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Cash from Operating Activities | 118.64 | 27.48 | 130.73 | 13.39 | 89.57 | 29.70 |
| Cash from Investing Activities | -125.37 | -37.35 | -315.81 | -26.70 | 112.93 | 94.57 |
| Cash from Financing Activities | -7.90 | 25.44 | 167.07 | 31.17 | -216.80 | 85.17 |
| Net Increase/Decrease in Cash | -14.63 | 15.58 | -18.01 | 17.86 | -14.30 | 209.44 |